AMN Healthcare Services (AMN) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 136.84%. A quarter ago, it was expected that this health care staffing company would post earnings of $0.52 per share when it actually produced earnings of $0.75, delivering a surprise of 44.23%.Over the las ...

Financial Performance - Revenue for Q1 2025 was $689.5 million, a decrease of 16% compared to $820.9 million in Q1 2024[16] - Gross profit for Q1 2025 was $198.1 million, down 23% from $257.5 million in Q1 2024[16] - Net loss for Q1 2025 was $1.1 million, compared to a net income of $17.3 million in Q1 2024[16] - The company reported a comprehensive loss of $1.0 million for Q1 2025, compared to a comprehensive income of $17.4 million in Q1 2024[16] - Total revenue for the three months ended March 31, 2025, was $689,533, a decrease of 15.9% compared to $820,878 for the same period in 2024[46] - Gross profit for Q1 2025 was $198,120, down 23.0% from $257,506 in Q1 2024[46] - Segment operating income for Q1 2025 was $81,950, a decline of 31.6% from $119,834 in Q1 2024[46] - Revenue decreased 16% to $689.5 million for the three months ended March 31, 2025, from $820.9 million for the same period in 2024, with the largest decline in the nurse and allied solutions segment[84] Cash Flow and Liquidity - Cash and cash equivalents at the end of Q1 2025 were $55.8 million, significantly up from $10.6 million at the end of Q4 2024[14] - Cash flows from operating activities for Q1 2025 were $92.7 million, an increase from $81.4 million in Q1 2024[22] - Net cash provided by operating activities increased to $92.7 million for the three months ended March 31, 2025, compared to $81.4 million in 2024[93] - Net cash used in investing activities for Q1 2025 was $26.0 million, compared to $21.4 million in Q1 2024, primarily due to a net purchase of investments of $14.5 million[98] - Net cash used in financing activities during Q1 2025 was $61.2 million, an increase from $39.0 million in Q1 2024, due to repayments of $95.0 million under the Senior Credit Facility[99] Assets and Liabilities - Total current assets increased to $627.4 million as of March 31, 2025, from $594.9 million at December 31, 2024[14] - Total liabilities decreased to $1.68 billion as of March 31, 2025, from $1.71 billion at December 31, 2024[14] - The company’s total stockholders' equity increased to $715.1 million as of March 31, 2025, from $706.6 million at December 31, 2024[14] - As of March 31, 2025, total cash, cash equivalents, and restricted cash amounted to $117,445 million, an increase from $97,473 million as of December 31, 2024[30] - The allowance for expected credit losses for accounts receivable decreased to $23,273 million as of March 31, 2025, from $31,796 million as of December 31, 2024[33] Segment Performance - The nurse and allied solutions segment revenue comprised 60% of total consolidated revenue for the three months ended March 31, 2025, down from 63% in the same period last year[72] - The physician and leadership solutions segment revenue increased to 25% of total consolidated revenue for the three months ended March 31, 2025, compared to 23% for the same period last year[73] - The technology and workforce solutions segment revenue accounted for 15% of total consolidated revenue for the three months ended March 31, 2025, up from 14% in the same period last year[74] - Travel nurse staffing revenue decreased to $215,447 in Q1 2025 from $334,369 in Q1 2024, representing a decline of 35.5%[46] - International nurse revenue totaled $33,872 in Q1 2025, down 31.4% from $49,469 in Q1 2024[47] - Nurse and allied solutions segment revenue decreased 20% to $413.3 million, primarily due to a 22% decrease in the average number of travelers on assignment[84] - Physician and leadership solutions segment revenue decreased 8% to $174.1 million, with a 10% decrease in the number of days filled impacting revenue[85] - Technology and workforce solutions segment revenue decreased 9% to $102.2 million, primarily due to a decline in VMS and outsourced solutions businesses[86] Operational Metrics - Operating expenses for Q1 2025 were $185.6 million, a reduction of 15% from $217.6 million in Q1 2024[16] - Selling, general and administrative expenses were $147.7 million, representing 21.4% of revenue, a slight increase from 21.3% in the previous year[90] - Days Sales Outstanding (DSO) remained stable at 55 days as of March 31, 2025, unchanged from December 31, 2024, but improved from 64 days in Q1 2024[97] - The average number of travelers on assignment in the first quarter decreased due to lower demand, with bill rates increasing slightly from the prior quarter[77] - Demand for locum tenens staffing in the physician and leadership solutions segment declined in the first quarter compared to both the prior year and prior quarter[78] Accounting and Reporting - The company adopted the new segment reporting standard effective for the fiscal year ended December 31, 2024, which requires enhanced disclosures about significant segment expenses[27] - The company is evaluating the impact of new accounting standards issued by the FASB, which may affect future disclosures[102][103] - The company recognized cumulative upward adjustments of $14,033 million and cumulative downward adjustments of $19,860 million related to its equity investment as of March 31, 2025[60] - The company has no material impairment charges recorded during the three months ended March 31, 2025 and 2024[61] Credit and Financing - The company has a $750,000 secured revolving credit facility, with an increased consolidated net leverage ratio covenant for the year ending December 31, 2025[49] - As of March 31, 2025, $150.0 million was drawn from a $750.0 million secured revolving credit facility, with $579.6 million available[94] - The company released $25,000 million of restricted cash in January 2025 to repay a portion of outstanding borrowings under the Senior Credit Facility[30] - The company entered into a fourth amendment to its credit agreement on November 5, 2024, increasing the consolidated net leverage ratio covenant for the year ending December 31, 2025[100] Miscellaneous - No shares of common stock were repurchased during the three months ended March 31, 2025[117] - There were no defaults upon senior securities reported[118] - Mine safety disclosures were not applicable for the reporting period[119] - No directors or officers adopted or modified any trading arrangements during the three months ended March 31, 2025[120] - The report includes various exhibits related to securities and performance restricted stock unit agreements[121]

Financial Data and Key Metrics Changes - The company reported first quarter revenue of $690 million, exceeding the high end of guidance by $10 million, primarily driven by strong performance in labor disruption, locum tenants, and allied businesses [6][18] - Adjusted EBITDA for the first quarter was $64 million, down 34% year over year and 15% sequentially, with an adjusted EBITDA margin of 9.3% [26] - The first quarter net loss was $1 million, compared to net income of $17 million in the prior year period [26] Business Line Data and Key Metrics Changes - Nurse and Allied Solutions revenue was $413 million, down 20% year over year, primarily due to lower volume and rates [19][20] - Travel nurse revenue decreased to $215 million, a 36% decline from the prior year [20] - Physician and Leadership Solutions segment revenue was $174 million, an 8% decrease year over year, with locum tenants revenue at $141 million, down 3% year over year [21][22] Market Data and Key Metrics Changes - The company experienced a 16% year-over-year decline in consolidated revenue, with a 6% sequential decrease [18] - Consolidated gross margin was 28.7%, slightly above guidance but down 270 basis points year over year [18][26] - Language services revenue increased by 5% year over year, while VMS revenue decreased by 33% year over year [25] Company Strategy and Development Direction - The company is focusing on enhancing its technology and automation capabilities to improve service delivery and operational efficiency [11][106] - AMN Healthcare is investing in AI tools to enhance recruiter productivity and improve service delivery [11][106] - The company aims to maintain operating leverage superior to competitors while generating cash flow for business investments and debt reduction [13] Management's Comments on Operating Environment and Future Outlook - Management noted that demand has not fully recovered to pre-pandemic levels in several business areas, including travel nursing and interim leadership [15] - The company is seeing heightened competition in language services, but believes it holds a distinct advantage due to high-quality solutions [16] - Management expressed confidence in the company's ability to support clients effectively while maintaining service quality [61] Other Important Information - The company generated $93 million in operating cash flow in the first quarter, reducing its revolving credit balance by $60 million [14][27] - The company has received industry recognition for innovation, including the 2025 Innovators Award from Modern Healthcare [14] Q&A Session Summary Question: Can you talk about the VMS and MSP wins? - Management indicated that recent wins reflect a strategy to broaden market positioning and are characterized as small to medium wins, with competitive nature [35][36] Question: What is the outlook for language services? - Management expects continued healthy growth in language services despite competitive pressures and recent consolidation in the space [39][40] Question: Are bill rates stabilizing in the travel nurse segment? - Management noted stabilization in bill rates and indicated that unfilled orders are at similar levels as before, suggesting a potential for future increases [45][46] Question: What are the capital allocation priorities? - The company prioritizes using free cash flow to pay down debt while continuing to invest in innovation and technology [90][92] Question: How is the international business expected to progress? - Management anticipates stabilization in the international business with expectations of positive growth in 2026 as visa dates move forward [83][85]

Financial Data and Key Metrics Changes - Consolidated revenue for Q1 2025 was $690 million, exceeding the high end of guidance by $10 million, driven by strong performance in labor disruption, locum tenants, and allied businesses [6][19] - Adjusted EBITDA for Q1 2025 was $64 million, down 34% year over year and 15% sequentially, with an adjusted EBITDA margin of 9.3% [26][27] - Consolidated gross margin was 28.7%, slightly above guidance but down 270 basis points year over year and 110 basis points sequentially [19][10] - The company reported a net loss of $1 million for Q1 2025, compared to net income of $17 million in the prior year [26][27] Business Line Data and Key Metrics Changes - Nurse and Allied Solutions revenue was $413 million, down 20% year over year, primarily due to lower volume and rates [20][21] - Travel nurse revenue decreased by 36% year over year to $215 million, while allied revenue was $147 million, down 13% year over year [21][22] - Physician and Leadership Solutions segment revenue was $174 million, an 8% decrease year over year, with locum tenants revenue at $141 million, down 3% year over year [22][23] - Technology and Workforce Solutions revenue was $102 million, down 9% year over year, with language services revenue increasing by 5% year over year to $75 million [24][25] Market Data and Key Metrics Changes - Demand for allied business grew mid-teens year over year, with bookings for the next school year trending towards growth [8][9] - The company noted heightened competition in language services, with industry consolidation leading to price competition [16][41] - The travel nurse market is experiencing intense competition, with some orders priced at levels that are not being filled [9][15] Company Strategy and Development Direction - The company is focused on enhancing technology and automation to improve service delivery and operational efficiency, including the rollout of new tools for recruiters [11][105] - AMN is investing in AI tools to reduce costs and improve service delivery, with a focus on maintaining high-quality service [11][105] - The company aims to leverage its diversified solutions to maintain operating leverage superior to competitors and generate cash flow for business investment [13][92] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to support clients amid ongoing labor disruption, emphasizing the importance of technology and automation [17][61] - The company anticipates continued demand growth in healthcare, despite some segments not recovering to pre-pandemic levels [15][81] - Management acknowledged a slowdown in client decision-making but noted strong demand across various business lines [94][82] Other Important Information - The company received industry recognition for innovation, being named one of the 15 innovative healthcare organizations by Modern Healthcare [14] - AMN continues to focus on debt reduction, with a net leverage ratio of 3.1 times [28][90] Q&A Session Summary Question: Can you talk about the VMS and MSP wins? - Management indicated that recent wins are small to medium in size but carry significant weight, reflecting a strategy to broaden market positioning [36][37] Question: What is the outlook for language services? - Management expects healthy growth in language services, despite competitive pressures and some margin decline [40][41] Question: Are bill rates stabilizing in the travel nurse segment? - Management noted stabilization in bill rates, with a premium spread of contingent costs to permanent labor at about 11% [46][47] Question: What is the impact of labor disruption on revenue? - Management stated that the increase in labor disruption revenue is due to improved internal focus and technology, with a stronger pipeline of opportunities [60][61] Question: How is the international business progressing? - Management expects stabilization in the international business, with a positive outlook for 2026 as visa dates move forward [83][85] Question: What are the capital allocation priorities? - The company prioritizes debt reduction while continuing to invest in innovation and technology [89][90]

EXHIBIT 99.1 AMN HEALTHCARE ANNOUNCES FIRST QUARTER 2025 RESULTS Quarterly revenue of $690 million; GAAP loss of ($0.03)/share and adjusted EPS of $0.45 Dollars in millions, except per share amounts. | | | | % Change Q1 | | --- | --- | --- | --- | | | | Q1 2025 | 2024 | | Revenue | $ | 689.5 | (16%) | | Gross profit | $ | 198.1 | (23%) | | Net loss | $ | (1.1) | nm | | Diluted loss per share | $ | (0.03) | nm | | Adjusted diluted EPS* | $ | 0.45 | (54%) | | Adjusted EBITDA* | $ | 64.2 | (34%) | * See "Non-G ...

Financial Performance - Consolidated revenue for Q1 2025 was $690 million, representing a 16% decrease year-over-year and a 6% decrease sequentially [3][6] - The company reported a net loss of $1 million, or ($0.03) per diluted share, compared to a net income of $17 million, or $0.45 per diluted share in Q1 2024 [6][26] - Adjusted diluted EPS for the quarter was $0.45, down 54% from $0.97 in the same quarter a year ago [3][12] Segment Performance - Revenue from the Nurse and Allied Solutions segment was $413 million, down 20% year-over-year and 9% sequentially [7] - The Physician and Leadership Solutions segment reported revenue of $174 million, an 8% decrease year-over-year but a 1% increase sequentially [8] - Technology and Workforce Solutions segment revenue was $102 million, a decrease of 9% year-over-year and 4% sequentially [9] Operational Highlights - Cash flow from operations was strong at $93 million, allowing the company to reduce debt by $60 million, resulting in a net leverage ratio of 3.1:1 [8][13] - The company achieved improved bookings driven by technology and process improvements, particularly in locum tenens revenue, which showed sequential growth [8] - AMN Healthcare was recognized in Modern Healthcare's 2025 Innovators Awards for its WorkWise workforce technology suite and AMN Passport mobile career platform [8] Guidance and Outlook - For Q2 2025, the company expects consolidated revenue to be between $645 million and $660 million, which is projected to be 11-13% lower than the prior year [14][15] - The guidance includes anticipated revenue declines across all segments, with Nurse and Allied Solutions expected to decrease by 14-17% year-over-year [15] - Gross margin for Q2 2025 is expected to be between 28.5% and 29.0% [14]

In Q4 2024 AMN Healthcare Services, Inc. ( AMN ) posted meaningful sequential revenue growth for the first time in 2 years, suggesting its cyclical decline might be coming to an end. In my latest article onI am a UK-based long-only investor with a strategy which revolves around finding companies which can be multi-baggers over a 5-10 year time horizon, though, as a great man once said, my favourite holding period is forever. I am looking for companies that have a high probability of substantial revenue and ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering AMN Healthcare Services (AMN) , which belongs to the Zacks Medical Services industry.When looking at the last two reports, this health care staffing company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 24.70%, on average, in the last two quarters.For the most recent quarter, AMN Healthcare was expected to ...

DALLAS, April 08, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook on Thursday, May 8, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare’s in ...

46% Plan to Leave Their Organizations in the Next 12 MonthsDALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Close to half of hospital, medical group and other healthcare facility leaders intend to leave their organizations during the next 12 months, according to a new survey examining the plans, perspectives and challenges facing healthcare executives in 2025. Conducted by B.E. Smith, a leading provider of healthcare executive search services and a company of AMN Healthcare, the 2025 Healthcare Leadership Trends ...